Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dermatology

Free Subscription 01.12.2025 1 Am J Pathol 11 BMC Cancer 9 Br J Dermatol 1 Cancer Lett 14 Clin Exp Dermatol 16 Eur J Dermatol 5 Int J Dermatol 3 J Cutan Pathol 9 J Dermatol 10 J Invest Dermatol 2 Lancet 2 Mycoses 1 Plast Reconstr Surg 1 PLoS Biol 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. ACCATTATIS FM, Gelsomino L, Manna L, Del Console P, et al
   Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor-positive Breast Cancer Cells.
   Am J Pathol. 2025 Sep 12:S0002-9440(25)00336.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. SPERLICH S, Geyer S, Holthausen-Markou S, Park-Simon TW, et al
   Breast cancer survivors' participation in social activities five years after primary surgery - are there social inequalities?
   BMC Cancer. 2025;25:1829.
   PubMed         Abstract available
   
   
3. COELHO LL, Vianna MM, da Silva DM, Gonzaga BMS, et al
   beta-lapachone impairs viability, migration, and epithelial-mesenchymal transition in mammary tumor spheroids.
   BMC Cancer. 2025;25:1826.
   PubMed         Abstract available
   
   
4. DENG Z, Li Y, Luo Y, Cao X, et al
   Nomogram models for prediction of axillary lymph node metastasis in breast cancer patients.
   BMC Cancer. 2025;25:1827.
   PubMed         Abstract available
   
   
5. YUAN S, Li J, Liu W, Ren M, et al
   CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis.
   BMC Cancer. 2025;25:1828.
   PubMed         Abstract available
   
   
6. ZHAO M, Zhao L, Yang Y, Wang F, et al
   Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.
   BMC Cancer. 2025;25:1808.
   PubMed         Abstract available
   
   
7. OJEDELE OA, Hamdi N, Mughram MHA, Alyami EM, et al
   Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling.
   BMC Cancer. 2025;25:1812.
   PubMed         Abstract available
   
   
8. ZHANG H, Yin X, Wang S, Li Q, et al
   Combined elevation of myeloid-derived suppressor cells and Tregs predicts lymph node metastasis in breast cancer.
   BMC Cancer. 2025;25:1806.
   PubMed         Abstract available
   
   
9. SHAWANA S, Mirza T, Khatoon A, Mushtaq S, et al
   Uncovering rare somatic variants in olfactory receptor genes in Pakistani triple-negative breast cancer patients.
   BMC Cancer. 2025;25:1799.
   PubMed         Abstract available
   
   
10. WANG A, Zeng P, Ma T, Shi H, et al
    Establishment of a new method for detection of TROP2-positive circulating tumor cells in breast cancer.
    BMC Cancer. 2025;25:1797.
    PubMed         Abstract available
    
    
11. YAN X, Zhang X, Wang Z, Yang L, et al
    Safety and efficacy of immune checkpoint inhibitors in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1804.
    PubMed         Abstract available
    
    
12. BUJA A, Cassalia F, Rugge M, Trevisiol C, et al
    Impact of comorbidities on survival in melanoma patients.
    BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15376.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

13. ZHAO M, Xu Z, Wu L, Wei Z, et al
    Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial.
    Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
    PubMed         Abstract available
    
    
14. XIANG Z, Chen G, Yin L, Xi X, et al
    Cutaneous toxicity and management in CEA-targeted Chimeric Antigen Receptor T-cell therapy for solid tumors.
    Br J Dermatol. 2025 Nov 24:ljaf473. doi: 10.1093.
    PubMed        
    
    
15. CHENG AY, Lin CC, Cheng AT, Chou MP, et al
    Incidence of skin cancer versus overall de novo malignancies among living donor liver transplant recipients in Taiwan: a cohort study.
    Br J Dermatol. 2025 Nov 24:ljaf472. doi: 10.1093.
    PubMed        
    
    
16. STERN R
    Cancer and Psoriasis: Known Risk factors explain the Association.
    Br J Dermatol. 2025 Nov 25:ljaf477. doi: 10.1093.
    PubMed        
    
    
17. FERTITTA L, Sarin KY, Romo CG, Bergqvist C, et al
    Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-D.
    Br J Dermatol. 2025 Nov 26:ljaf479. doi: 10.1093.
    PubMed         Abstract available
    
    
18. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
    Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden.
    Br J Dermatol. 2025 Nov 26:ljaf478. doi: 10.1093.
    PubMed         Abstract available
    
    
19. GOMEZ-TOMAS A, Gonzalez-Cruz C, Garcia-Patos V, Ferrandiz-Pulido C, et al
    Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients.
    Br J Dermatol. 2025 Nov 27:ljaf483. doi: 10.1093.
    PubMed         Abstract available
    
    
20. KNOPFEL N, Barberan-Martin S, Polubothu S, Sauvadet A, et al
    Gene discovery in extensive dermal melanocytosis reveals multiple mosaic causes.
    Br J Dermatol. 2025 Nov 27:ljaf481. doi: 10.1093.
    PubMed         Abstract available
    
    
21. MILTNER LA, Loman L, Ortiz JA, Zhang J, et al
    Multimorbidity and Atopic Dermatitis in a Population-Based Cohort: Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
    Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Lett

22. KRAWCZYNSKA N, Wang Y, Lim K, Das Gupta A, et al
    Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells.
    Cancer Lett. 2025 Oct 28:218105. doi: 10.1016/j.canlet.2025.218105.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

23. CLARKE E, van Bodegraven B, Shipman AR
    Does ciclosporin cause symptomatic hypomagnesaemia in psoriasis patients included in the British Association of Dermatologists Biologics and Immunomodulators Registry (BADBIR) pharmacovigilance registry?
    Clin Exp Dermatol. 2025 Nov 21:llaf520. doi: 10.1093.
    PubMed        
    
    
24. YAO H, Wu Y, Li J, Zhang R, et al
    Hypereosinophilic dermatitis misdiagnosed as chronic eczema in an elderly male with multiple comorbidities.
    Clin Exp Dermatol. 2025 Nov 25:llaf512. doi: 10.1093.
    PubMed        
    
    
25. SILVA I, Miriyala S, Khattri S
    Efficacy and response of the use of biologic and small-molecule combination therapy in adults with atopic dermatitis.
    Clin Exp Dermatol. 2025;50:2493-2495.
    PubMed        
    
    
26. HUA S, Fang B, Liu Y, Hu Z, et al
    A novel missense mutation responsible for a unique erythrokeratodermia variabilis patient with skin lesions in a swirling pattern.
    Clin Exp Dermatol. 2025 Nov 26:llaf510. doi: 10.1093.
    PubMed         Abstract available
    
    
27. YAN Y, Wang D, Wang P, Wu Y, et al
    Effect of 5-aminolaevulinic acid photodynamic therapy followed by sequential 30% supramolecular salicylic acid treatment in moderate-to-severe acne vulgaris: a prospective, randomized, split-face controlled study.
    Clin Exp Dermatol. 2025;50:2439-2447.
    PubMed         Abstract available
    
    
28. SIN-SOLER M, Louka M, Garbayo-Salmons P, Torrelo A, et al
    Hidradenitis suppurativa in paediatric patients with Down syndrome: a comparative study of 116 participants.
    Clin Exp Dermatol. 2025;50:2418-2424.
    PubMed         Abstract available
    
    
29. OLSHINKA A, Harris Rimon G, Lapidoth M, Mimouni D, et al
    Pyogenic granuloma-like Spitz naevus in paediatric patients: a case series.
    Clin Exp Dermatol. 2025;50:2392-2396.
    PubMed         Abstract available
    
    
30. SEARLE T, Al-Niaimi F, Ali FR
    Modulation of the microbiome: a paradigm shift in the treatment of acne.
    Clin Exp Dermatol. 2025;50:2357-2364.
    PubMed         Abstract available
    
    
31. JIANG X, Lai W, Gao X, Zeng W, et al
    Efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: a multicentre randomized, double-blind, placebo-controlled superiority study.
    Clin Exp Dermatol. 2025;50:2410-2417.
    PubMed         Abstract available
    
    
32. OTA VK, Mariath LM, Torrelio RMF, Arashiro CS, et al
    Genetic profiling of epidermolysis bullosa in a large Brazilian cohort.
    Clin Exp Dermatol. 2025;50:2397-2409.
    PubMed         Abstract available
    
    
33. SHEERN C, Levell NJ, Craig PJ, Jeffrey P, et al
    Mycosis fungoides: a review.
    Clin Exp Dermatol. 2025;50:2365-2375.
    PubMed         Abstract available
    
    
34. VYAS J, Johns JR, Trivedi A, Ali FM, et al
    Systematic review of the use of the Dermatology Life Quality Index in routine clinical practice: evidence from 287 articles across 56 countries.
    Clin Exp Dermatol. 2025;50:2456-2465.
    PubMed         Abstract available
    
    
35. ERAIFEJ N, Jupe T, Grundmann A, Blythe A, et al
    Exploring the use of instructional dermatology surface models within a dermatology-focused objective structured clinical examination station for medical students.
    Clin Exp Dermatol. 2025;50:2473-2477.
    PubMed         Abstract available
    
    
36. WARREN Z, West C, Sander C, Lai FYX, et al
    TYK-ed off by rosacea: an Australian case series of rosacea associated with deucravacitinib.
    Clin Exp Dermatol. 2025;50:2482-2485.
    PubMed         Abstract available
    
    

    
    Eur J Dermatol

37. MUNEISHI Y, Oyama N, Hasegawa M
    A paediatric case of solitary cutaneous mastocytoma with progression to urticaria pigmentosa: phenotypic transition or dual phenotype?
    Eur J Dermatol. 2025;35:410-411.
    PubMed        
    
    
38. MUNCEY-BUCKLEY M, Chin G, Brocklehurst P, Morton C, et al
    Identification and prioritisation of skin cancer-related use cases for dermatological artificial intelligence tools.
    Eur J Dermatol. 2025;35:413-415.
    PubMed        
    
    
39. SUZUKI Y, Yanagisawa H, Jin L, Arai E, et al
    Polypoid basal cell carcinoma arising in the inguinal region.
    Eur J Dermatol. 2025;35:415-417.
    PubMed        
    
    
40. TOYOSHIMA M, Nakaoji K, Hamada K, Yamanaka A, et al
    Analysis of skin aging patterns using a facial imaging system in atopic dermatitis patients of 20-34 years old.
    Eur J Dermatol. 2025;35:424-426.
    PubMed        
    
    
41. FUKAI R, Hamaguchi Y, Kitano T, Komatsu N, et al
    Severe relapse of cutaneous polyarteritis nodosa triggered by bacterial cellulitis.
    Eur J Dermatol. 2025;35:427-429.
    PubMed        
    
    
42. SAKIYAMA T, Furuta K
    Rare coexistence of generalized pustular psoriasis and discoid lupus erythematosus with worsening of lupus lesions after bimekizumab therapy: a case report.
    Eur J Dermatol. 2025;35:432-433.
    PubMed        
    
    
43. HIOKI T, Kamiya H, Hayano K, Kuze B, et al
    Concurrent granulomatous skin and nasal lesions likely induced by adalimumab for ulcerative colitis: a unique case of localized drug-induced granulomatosis.
    Eur J Dermatol. 2025;35:433-435.
    PubMed        
    
    
44. GONZALEZ JM, Sanchez BR, Briones LJ, Goller S, et al
    Journal Club. Genetic pathways in melanoma: molecular foundations and clinical implications.
    Eur J Dermatol. 2025;35:442-444.
    PubMed        
    
    
45. BRIONES LJ, Sanchez BR, Piqueras PG, Parra V, et al
    Childhood lupus erythematosus panniculitis.
    Eur J Dermatol. 2025;35:445-446.
    PubMed        
    
    
46. FERREIRA CS, Sousa M, Contente M, Torres T, et al
    Successful use of risankizumab in a patient with severe psoriasis and active lung adenocarcinoma.
    Eur J Dermatol. 2025;35:446-448.
    PubMed        
    
    
47. ZAVATTARO E, Airoldi C, Veronese F, Cammarata E, et al
    From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign.
    Eur J Dermatol. 2025;35:361-368.
    PubMed         Abstract available
    
    
48. PRIMERANO A, Floriddia G, De Domenico E, Collina MC, et al
    Localized dominant dystrophic epidermolysis bullosa worsened by diabetes.
    Eur J Dermatol. 2025;35:369-376.
    PubMed         Abstract available
    
    
49. AN Q, Li K, Yang B
    Association between stem cell growth factor beta and fibrotic skin diseases.
    Eur J Dermatol. 2025;35:377-386.
    PubMed         Abstract available
    
    
50. BEYRON A
    Keratosis pilaris: a systematic review of the literature and strategies for optimal treatment.
    Eur J Dermatol. 2025;35:387-393.
    PubMed         Abstract available
    
    
51. CHEN G, Zhang Y, Cui M, Li H, et al
    Co-occurrence of two monogenic diseases within a single family.
    Eur J Dermatol. 2025;35:394-400.
    PubMed         Abstract available
    
    
52. LI Y, Zeng Q, Cao QY, Zhao AQ, et al
    Hypohidrotic ectodermal dysplasia: association between EDA mutations and hypotrichosis - a case series.
    Eur J Dermatol. 2025;35:401-407.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

53. ZHAO Y, Zhang L, Wu L, Yang B, et al
    Efficacy and Safety of Anti-IL-4Ralpha Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis.
    Int J Dermatol. 2025 Nov 21. doi: 10.1111/ijd.70175.
    PubMed         Abstract available
    
    
54. MORTAZAVI H, Firooz A, Khatami A, Khamesipour A, et al
    Erysipeloid Cutaneous Leishmaniasis in the Old World: A Systematic Review.
    Int J Dermatol. 2025 Nov 26. doi: 10.1111/ijd.70142.
    PubMed         Abstract available
    
    
55. BRIATICO G, Scharf C, Nicoletti MM, Petti A, et al
    Comparison of Clinical and Dermoscopic Features Between Micronodular and Nodular Basal Cell Carcinoma.
    Int J Dermatol. 2025 Nov 26. doi: 10.1111/ijd.70163.
    PubMed        
    
    
56. ARMARIO-HITA JC, Galan-Gutierrez M, Pereyra-Rodriguez JJ, Suarez-Perez J, et al
    Real-World Effectiveness and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Multicenter Study From Spain.
    Int J Dermatol. 2025 Nov 27. doi: 10.1111/ijd.70185.
    PubMed        
    
    
57. ROB F, Kojanova M, Hercogova JT, Balaz M, et al
    Efficacy and Safety Evaluation of Different Lebrikizumab Dosages in Atopic Dermatitis Patients Over 16 to 24 Weeks: A BIOREP Registry Analysis.
    Int J Dermatol. 2025 Nov 28. doi: 10.1111/ijd.70180.
    PubMed        
    
    

    
    J Cutan Pathol

58. CHENG A, Gruchy J, Burns A, Langley R, et al
    Deep Dermal and Subcutaneous Deposits in Thin Melanoma: A Cautionary Tale.
    J Cutan Pathol. 2025 Nov 27. doi: 10.1111/cup.70025.
    PubMed         Abstract available
    
    
59. HULSE J, Swanson A, O'Donnell E, Fraga G, et al
    Diagnostic Accuracy of Immunohistochemistry Testing on Sebaceous Gland Neoplasms for Muir-Torre Syndrome: A Meta-Analysis.
    J Cutan Pathol. 2025 Nov 27. doi: 10.1111/cup.70026.
    PubMed         Abstract available
    
    
60. WANG X, Huang Y
    The Diagnostic Value of Autofluorescence in Hematoxylin-Eosin-Stained Sections for Cutaneous Sporotrichosis.
    J Cutan Pathol. 2025 Nov 24. doi: 10.1111/cup.70022.
    PubMed         Abstract available
    
    

    
    J Dermatol

61. MINAKAWA S, Matsuzaki Y, Hashimoto T, Ishii N, et al
    Lichenoid Drug Eruption due to Telmisartan-Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70068.
    PubMed        
    
    
62. OKAZAKI T, Terui H, Takahashi T, Kobayashi A, et al
    Coronary Artery Disease Assessment in Psoriasis Patients Well-Controlled Under Systemic Anti-Inflammatory Treatments-A Real-World Observational Study From a Single Center.
    J Dermatol. 2025 Nov 24. doi: 10.1111/1346-8138.70069.
    PubMed         Abstract available
    
    
63. KATAYAMA S, Nishihara K, Kohri N, Yoshida S, et al
    Successful Treatment of BRAF(V600R)-Mutant Melanoma of Unknown Primary Identified by Liquid Biopsy With BRAF/MEK Inhibitors.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70080.
    PubMed        
    
    
64. IRIE K, Yamamoto M, Yamamoto T
    Disseminated Fibrous Papules of the Lip.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70064.
    PubMed        
    
    
65. TOYOSHIMA R, Aso S, Matsui H, Fushimi K, et al
    Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database.
    J Dermatol. 2025 Nov 26. doi: 10.1111/1346-8138.70082.
    PubMed         Abstract available
    
    
66. HIRAISHI A, Kamiya K, Sugihara N, Komine M, et al
    A Case of Palmoplantar Psoriasis Successfully Treated With Tapinarof Cream.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70079.
    PubMed        
    
    
67. JIAO S, Su D, Si S, Zhang N, et al
    Risk Factors for Drug-Induced Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis.
    J Dermatol. 2025 Nov 27. doi: 10.1111/1346-8138.70063.
    PubMed         Abstract available
    
    
68. ENDO M, Yamamoto T
    Lichen Nitidus in a Patient With Systemic Sarcoidosis.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70087.
    PubMed        
    
    
69. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

70. VAN EE A, Garza LA
    New Insights into the Neglected Disease Vulvar Lichen Sclerosus.
    J Invest Dermatol. 2025 Nov 21:S0022-202X(25)03416.
    PubMed        
    
    
71. LAN J, Jiang B, Zhang X, Xia Y, et al
    CD36-mediated long-chain fatty acids transport in keratinocytes promotes psoriasis-like skin inflammation through increasing mitochondrial reactive oxygen species.
    J Invest Dermatol. 2025 Nov 20:S0022-202X(25)03555.
    PubMed         Abstract available
    
    
72. DASGUPTA R, Park PH, Wallace M, Marzula V, et al
    A CD206 targeting peptide exhibits preclinical therapeutic efficacy in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03607.
    PubMed        
    
    
73. RAJA DAVID ISAC EB, Sigurbjornsdottir S, Dilshat R, Cornell RA, et al
    Phenotype switching in melanoma cells: MITF regulates the expression of CDH1 through E-boxes in an intronic region.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03605.
    PubMed         Abstract available
    
    
74. WU CY, Vadhan A, Wei WY, Yu HS, et al
    Luteinizing Hormone Induces Murine Hair Loss through Transient Receptor Potential Canonical Channel-Mediated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis.
    J Invest Dermatol. 2025;145:2989-2997.
    PubMed         Abstract available
    
    
75. TOBIAS R, Kumar S, Liu J, Lenci N, et al
    Unrestrained MyD88 Signaling in A20-Deficient Keratinocytes Triggers T-Cell-Dependent Psoriatic Arthritis-Like Disease.
    J Invest Dermatol. 2025;145:2998-3010.
    PubMed         Abstract available
    
    
76. QIN M, Evron E, Tran PT, Deng M, et al
    Immune Activation and Glycolytic Responses to Cutibacterium acnes Cell Wall Polysaccharides.
    J Invest Dermatol. 2025;145:3126-3137.
    PubMed         Abstract available
    
    
77. LUKAS D, Liu X, Reibetanz M, Konen-Waisman S, et al
    Innate Lymphoid Cell 1- and NK Cell-Derived, Early IFNg Release Depends on ICER and Promotes Protection against Leishmania major Infection.
    J Invest Dermatol. 2025;145:3138-3144.
    PubMed         Abstract available
    
    
78. QIU X, Feng Y, Mo X, Ju Q, et al
    Multi-Omics Analysis Identifies Genetic Mechanisms and Therapeutic Targets for Acne Vulgaris.
    J Invest Dermatol. 2025;145:3037-3050.
    PubMed         Abstract available
    
    
79. NEEDLE CD, Brinks AL, Perez OD, Shapiro J, et al
    A Comprehensive Review of GWASs of Human Hair Traits.
    J Invest Dermatol. 2025;145:2964-2972.
    PubMed         Abstract available
    
    

    
    Lancet

80. GUTTMAN-YASSKY E, Kabashima K, Worm M, Luna PC, et al
    Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
    Lancet. 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
    PubMed         Abstract available
    
    
81. ATASH K, Boesjes CM, de Bruin-Weller MS
    Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.
    Lancet. 2025 Nov 25:S0140-6736(25)02152-X. doi: 10.1016/S0140-6736(25)02152.
    PubMed        
    
    

    
    Mycoses

82. WANG J, Gow NAR, Brewer MG
    Candida albicans Enhances Protease Activity and Activates MyD88-Dependent IL-1beta Production in Human Keratinocytes.
    Mycoses. 2025;68:e70133.
    PubMed         Abstract available
    
    
83. CHEN SJ, Chen S, Wang Y
    Global Burden of Fungal Skin Diseases and Future Projections: An Analysis of the 2021 Global Burden of Disease Study.
    Mycoses. 2025;68:e70134.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

84. KIM J, Lee DY, Lee KT, Mun GH, et al
    Foot Melanoma Reconstruction Using Refined Perforator Flap: Safety, Function, and Subregional Surgical Strategy.
    Plast Reconstr Surg. 2025 Nov 25. doi: 10.1097/PRS.0000000000012655.
    PubMed         Abstract available
    
    

    
    PLoS Biol

85. MAO F, Wu S, Allison DB, He D, et al
    The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1.
    PLoS Biol. 2025;23:e3003490.
    PubMed         Abstract available
    
    

    
    PLoS One

86. STUTZIN DONOSO F, Archer S, Walter FM, Morris S, et al
    CanRisk-GP protocol: A feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice.
    PLoS One. 2025;20:e0336902.
    PubMed         Abstract available
    
    
87. WOGAYEHU BT
    Self-reported prevalence of hand eczema and associated factors among hair dressers of Debre Berhan City in North Eastern Ethiopia.
    PLoS One. 2025;20:e0336974.
    PubMed         Abstract available
    
    
88. VAN CAPPELLEN-VAN MALDEGEM SJM, Kruif A, Seidell JC, van de Poll-Franse LV, et al
    Determinants and timing of lifestyle changes in postmenopausal breast cancer survivors: A longitudinal qualitative study.
    PLoS One. 2025;20:e0337089.
    PubMed         Abstract available
    
    
89. LI W, Wang X, Yu Q, Zhou W, et al
    Symptom network analysis in breast cancer patients: A scoping review.
    PLoS One. 2025;20:e0336793.
    PubMed         Abstract available
    
    
90. ZENG J, Lin L, Ma Y, Huang W, et al
    Single-cell transcriptomics profiling reveals cellular origins and molecular drivers underlying melanoma brain metastasis.
    PLoS One. 2025;20:e0336502.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.